Literature DB >> 23018460

Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.

Ryoji Ito1, Ikumi Katano, Miyuki Ida-Tanaka, Tsutomu Kamisako, Kenji Kawai, Hiroshi Suemizu, Sadakazu Aiso, Mamoru Ito.   

Abstract

Xenograft animal models using immunodeficient mice have been widely applied in medical research on various human diseases. NOD/Shi-scid-IL2rγ(null) (NOG) mice are known to show an extremely high engraftment rate of xenotransplants compared with conventional immunodeficient mice. This high engraftment rate of xenotransplants in NOG mice was substantially suppressed by the transfer of spleen cells from NOD-scid mice that were devoid of NK cells. These results indicate that cell types other than splenic NK cells present in NOD-scid mice but not in NOG mice may be involved in this suppression. To identify the cell types responsible for this effect, we transferred subpopulations of spleen cells from NOD-scid mice into NOG mice and assessed the levels of human cell engraftment after human PBMC (hPBMC) transplantation. These experiments revealed that CD11c(+)B220(+) plasmacytoid dendritic cells (pDCs) from NOD-scid mice markedly inhibited engraftment of human cells. The CD11c(+)B220(+)CD122(+) cells further fractionated from the pDCs based on the expression of CD122, which is an NK cell marker strongly inhibited during hPBMC engraftment in NOG mice. Moreover, the CD122(+) cells in the pDC fraction were morphologically distinguishable from conventional CD122(+) NK cells and showed a higher rejection efficiency. The current results suggest that CD11c(+)B220(+)CD122(+) cells play an important role in xenograft rejection, and their absence in NOG mice may be critical in supporting the successful engraftment of xenotransplants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018460     DOI: 10.4049/jimmunol.1200820

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

2.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

3.  A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis.

Authors:  Ryoji Ito; Shuichiro Maruoka; Kaori Soda; Ikumi Katano; Kenji Kawai; Mika Yagoto; Asami Hanazawa; Takeshi Takahashi; Tomoyuki Ogura; Motohito Goto; Riichi Takahashi; Shota Toyoshima; Yoshimichi Okayama; Kenji Izuhara; Yasuhiro Gon; Shu Hashimoto; Mamoru Ito; Satoshi Nunomura
Journal:  JCI Insight       Date:  2018-11-02

4.  Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.

Authors:  Tetsuya Ito; Yutaka Sendai; Satoshi Yamazaki; Marie Seki-Soma; Kensuke Hirose; Motoo Watanabe; Kazuo Fukawa; Hiromitsu Nakauchi
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

5.  Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma.

Authors:  Lukasz Kuryk; Anne-Sophie W Møller; Magnus Jaderberg
Journal:  J Med Virol       Date:  2019-06-24       Impact factor: 2.327

6.  Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis.

Authors:  Wei Rao; Shan Wang; Marcin Duleba; Suchan Niroula; Kristina Goller; Jingzhong Xie; Rajasekaran Mahalingam; Rahul Neupane; Audrey-Ann Liew; Matthew Vincent; Kenichi Okuda; Wanda K O'Neal; Richard C Boucher; Burton F Dickey; Michael E Wechsler; Omar Ibrahim; John F Engelhardt; Tinne C J Mertens; Wei Wang; Soma S K Jyothula; Christopher P Crum; Harry Karmouty-Quintana; Kalpaj R Parekh; Mark L Metersky; Frank D McKeon; Wa Xian
Journal:  Cell       Date:  2020-04-15       Impact factor: 41.582

7.  Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis.

Authors:  Takeshi Takahashi; Ikumi Katano; Ryoji Ito; Motohito Goto; Hayato Abe; Seiya Mizuno; Kenji Kawai; Fumihiro Sugiyama; Mamoru Ito
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.